In other work, 15 MAPT mutations were associated with PSP, while LRRK2 has been identified as an infrequent monogenic risk factor of PSP, and it has been demonstrated that DCTN1 mutations may imitate PSP syndromes. Here, LRRK2 is linked to supranuclear palsy, progressive, 1.